about
Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspectsPediatric reference Raman data for material characteristics of iliac trabecular bone.Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults.Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX).Nucleation and growth of mineral crystals in bone studied by small-angle X-ray scattering.COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women.Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.Lifelong challenge of calcium homeostasis in male mice lacking TRPV5 leads to changes in bone and calcium metabolism.Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility.Classification of osteogenesis imperfecta.Bone mass and mineralization in osteogenesis imperfecta.Fkbp10 Deletion in Osteoblasts Leads to Qualitative Defects in Bone.Collagen cross-linking influences osteoblastic differentiation.The regulatory role of thyroid hormones in bone cell growth and differentiation.The expression of matrix metalloproteinase-13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25-dihydroxyvitamin D3 and thyroid hormones.Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells.Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone.Collagen packing and mineralization. An x-ray scattering investigation of turkey leg tendon.Biomimetic mineral-organic composite scaffolds with controlled internal architecture.Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse.Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells.Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate.Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment.The vitamin D analog ZK191784 normalizes decreased bone matrix mineralization in mice lacking the calcium channel TRPV5.Effects of tumor-induced osteomalacia on the bone mineralization process.Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome.Bone matrix hypermineralization in prolyl-3 hydroxylase 1 deficient mice.Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.Mineralized microstructure of calcified avian tendons: a scanning small angle X-ray scattering study.Effects of Odanacatib on bone mineralization density distribution in thoracic spine and femora of ovariectomized adult rhesus monkeys: a quantitative backscattered electron imaging study.The transient receptor potential channel TRPV6 is dynamically expressed in bone cells but is not crucial for bone mineralization in mice.Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect.TRPV4 deficiency causes sexual dimorphism in bone metabolism and osteoporotic fracture risk.Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in Mineralization.Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.
P50
Q27025945-FE0F4CB8-942E-4734-8F43-92A03B548F12Q30854490-22A4AAE4-CFB0-44EA-947D-701DB2696CCEQ33415776-5CCA010C-73B8-4F6D-82F7-4FA85150393CQ33478690-E63BCA1C-FB60-48EF-9E38-2851D0816A43Q34130828-D324A845-2C8F-48CA-8B90-EF01062D9301Q35012002-8452A7DD-7194-4126-9F89-DDC7D556543DQ35731108-E4E0AC48-4044-449F-AA6D-4FAF354AEC0DQ35740740-53E148D7-F6EB-464A-AAA8-3476479FB8DEQ37295235-BAF2E499-97ED-436B-A407-37B76E113AE6Q37380294-55D6C177-C0A0-41C9-8FE6-65CDCB230283Q38553650-5347F901-B8CF-404F-AB12-65F18F5AB100Q38553653-B23AEA93-E2EA-49CE-A711-66BC8E604D18Q38958086-4E4EC1E3-94C2-4191-A432-872E129A05CAQ39980880-51CF1C6F-BDD7-4904-ABE0-CC8D4D70AAF7Q40439577-F2CFD57A-CC7D-422F-924C-01ACA66C9C86Q40640898-C5D8259E-6228-498B-949B-04B5AFC1E687Q41010291-743C3CE3-194F-436D-915E-707683C377AEQ41124398-555B4BAE-6E99-4D2D-90D1-3B400D6D00FCQ41632079-DF983EF2-F8C7-4E4C-AC8A-813F94518D03Q42584065-DEFC251E-6C20-4BFA-9AFA-19A02EA19284Q42806966-215850BF-82EC-496D-9A73-4853A07254B4Q42823675-768097CF-B0BC-4C38-BD64-D4580ED4DB12Q42832433-BE06D970-5828-4CA8-94A5-4BEA3FBC2027Q42947283-76EDDD08-9B7A-4640-960D-FB13FDFA17D5Q43076378-B1C0005F-0336-42B5-BCBF-CA47E8C036BBQ44792265-BF511FCA-BADE-45B0-B2AE-D232F75529FEQ46121176-5406943D-73A8-4E1B-AF2F-6C69FE77AB98Q46274255-C6A8DD6B-B881-4E6E-B67D-BE54E058B6D0Q46278866-0F3683D8-5CE7-4616-A23B-22059F6DCB24Q46279639-DC308FFB-E4A3-43C3-A6A0-40789C39DF75Q46283861-44221E11-5AB6-47BF-B581-6CBB3F244708Q46287203-EC33DF78-CDC9-4BC5-900E-5E0E9A890025Q46289368-B98032C6-3B08-4E4F-AA51-296DC023E478Q46293365-E97C7FA4-8678-4A94-A694-9BD39992FBEAQ47196656-DE6557D6-D8A7-42F6-8284-43548BE537D6Q50172805-33382D4A-B799-4058-A3CD-CBAC6FB6E354Q51092170-0789F231-AA85-4663-8AEF-223AD5A1118EQ51198243-88064D3E-117B-4D03-940D-AC3F638115CAQ52718216-F8569DC8-729E-493F-BEE4-6362EA21EF13Q53215245-5A116655-28DB-4F0F-8FDB-38F710428672
P50
description
researcher ORCID ID = 0000-0003-1164-1877
@en
wetenschapper
@nl
name
N Fratzl-Zelman
@ast
N Fratzl-Zelman
@en
N Fratzl-Zelman
@nl
type
label
N Fratzl-Zelman
@ast
N Fratzl-Zelman
@en
N Fratzl-Zelman
@nl
prefLabel
N Fratzl-Zelman
@ast
N Fratzl-Zelman
@en
N Fratzl-Zelman
@nl
P31
P496
0000-0003-1164-1877